Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1091097C details a safe, high-purity route for N-substituted glycine esters, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN112574112B details a green oxidative synthesis for N-substituted 2H-indazoles. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN111018734B reveals a cost-effective route for cinacalcet intermediates using Meldrum's acid, offering reliable supply chain solutions and reduced manufacturing costs for global pharma.
Advanced synthesis of 2-methoxy-4-methylbenzylamine via safe reductive amination. Offers significant cost reduction in fine chemical manufacturing and high purity.
Patent CN102898356A details a scalable route for Prucalopride intermediates. Discover cost-effective hydrogenation strategies and supply chain advantages for API manufacturing.
Patent CN114085158A discloses a one-step room temperature synthesis for 4,4'-diaminodiphenyl ether. This method offers significant cost reduction and high purity for polyimide manufacturing.
Patent CN106631991B details a safer, platinum-free synthesis route for hindered amine light stabilizer intermediates, offering significant cost and safety advantages.
Patent CN116621810A reveals a stable synthesis route for 2-methyl nicotine. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN111646917A details a metal-free route to N-(4-iodophenyl) amides using m-CPBA and HFIP, offering cost reduction and high purity for pharmaceutical intermediates.
Patent CN102675135A details a mild, high-yield method for synthesizing alpha-amino acid esters using triethylamine catalysis, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN102311440B details a novel 5-step synthesis for high-purity diazabicyclo octane intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111470983A details a high-yield synthesis of bromhexine hydrochloride. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN110003275A details a high-yield synthesis of 4,6-bis(diphenylphosphino)phenazine ligands. Discover cost-effective manufacturing and supply chain advantages for industrial catalysis.
Patent CN106083689A reveals a novel Silodosin synthesis route offering high purity and reduced impurities for reliable pharmaceutical intermediate supply chains.
Novel aluminum catalyst enables anti-Markovnikov hydroamination with high yield. Reduces cost and improves supply chain reliability for amine synthesis.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Discover a novel selenium-catalyzed method for propargyl alpha-amino boronate synthesis. Offers mild conditions, broad substrate scope, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113548971A reveals a novel reductive amination route for spermidine. This process offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN103214407B details silver-catalyzed sp3 C-H amination for tetrahydropyrrole derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Discover the atom-economical synthesis of 1,5-benzodiazepine derivatives using gold catalysis. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.